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IA The World Health Organization recommends that oral pre-exposure prophylaxis (PrEP), antiretroviral medication taken by HIV-uninfected persons to prevent HIV, be offered as a prevention choice for 
people at substantial risk of HIV infection. Adolescent girls and 
young women (AGYW) in Tanzania are particularly vulnerable 
to HIV infection due to several factors including early marriage, 
having older sexual partners, and challenges in negotiating safe 
sex.1 HIV prevalence among adolescent girls aged 15–19 years 
is 1.3 percent, and nearly four times higher (4.4 percent) among 
young women aged 20–24.1 PrEP has the potential to substantially 
reduce HIV acquisition among AGYW in Tanzania as part of a 
comprehensive HIV prevention package, provided they can access, 
use, and adhere to the medication.2–5 
Policymakers, programmers, and other stakeholders are currently 
considering PrEP for AGYW in Tanzania. Understanding AGYW’s 
attitudes and perceptions about PrEP is critical to ensuring 
that introduction is done is a manner that reduces barriers and 
optimizes facilitators of PrEP acceptance and use. 
The Population Council, in collaboration with the National AIDS 
Control Programme (NACP) and CSK Research Solutions Ltd, is 
conducting implementation science research in Tanzania to identify 
key considerations for introducing PrEP to AGYW. The research sites 
consist of one urban and one rural setting in Dar Es Salaam and 
Mbeya districts, respectively. This brief presents results from our 
qualitative in-depth interviews (IDIs) and focus group discussions 
(FGDs) with AGYW.
METHODS
Study team researchers conducted 24 IDIs and 4 FGDs in Kiswahili 
with sexually active, HIV-negative AGYW aged 15–24 years. FGDs 
consisted of unmarried AGYW while IDIs included married AGYW and 
unmarried female sex workers (FSWs). Trained research assistants 
used a standardized script to provide detailed information on PrEP 
to all AGYW. Placebo PrEP pills were shown to AGYW as part of 
the interviews. This study was approved by the Population Council 
Institutional Review Board (New York, USA) and the National 
Institute of Medical Research (Dar Es Salaam, Tanzania). 
ADOLESCENT GIRLS AND YOUNG WOMEN’S 
PERCEPTIONS OF ORAL PRE-EXPOSURE 
PROPHYLAXIS INTRODUCTION IN TANZANIA
FINDINGS FROM IMPLEMENTATION SCIENCE RESEARCH
KEY FINDINGS AND  
RECOMMENDATIONS
Rollout PrEP to AGYW:  AGYW express 
a strong need for PrEP as they perceive 
themselves at high risk of HIV because of 
lack of trust in relationships and unequal 
gender power dynamics.
Address barriers to use: These include 
AGYW’s fear of stigma, side effects, and 
the impact of PrEP on their relationship.  
Enact and promote facilitators of 
adherence: Community education and 
sensitization about PrEP, knowing one is 
HIV negative from routine testing, being 
able to access PrEP free or at low cost, 
and integrating PrEP within other health 
services would facilitate PrEP adherence 
by AGYW.
To effectively introduce PrEP to AGYW, we need 
to understand their lived experiences and 
engage them in research, program planning, 
and policy making around PrEP.
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2  │ AGYW’s perceptions of oral PrEP introduction in Tanzania
RESULTS 
AGYW express a strong need for 
PrEP as they perceive themselves 
at high risk of HIV
 
Study participants have a sophisticated awareness of 
their own risk and their sexual partner’s risk of HIV, but 
often feel powerless to change their own behavior. 
• AGYW, regardless of partnership status, express a high 
level of anxiety about becoming infected with HIV due 
to distrust surrounding their partner’s sexual behaviors 
outside of their relationship. There are strong cultural 
and gender norms that prohibit a woman from refusing 
to have sex with her husband or a long-term partner. 
“...I am aware that at any moment I could get the HIV infection. ...I am not sure of where he has been..., he might have contracted the disease from there. Since he is my partner and I depend on him, I fail to resist. 
But frankly speaking, my thoughts are usually 
on being HIV infected during such occasions. 
–FSW, IDI, age 23, Dar es Salaam 
“Things that will put me at risk for HIV are such as my own partner, because I will not be sure of what he is doing out there, he might be hanging out with other women. 
He is my husband he will need to have sex 
with me, I cannot resist him, I must accept his 
requests.    
–Married AGYW, IDI, age 19, Mbeya
• FSWs, in particular, view themselves at high risk of 
HIV due to such factors as lack of condom use with 
clients, high reported instances of unprotected anal 
sex, sharing clients among one another, and sexual 
violence. 
“Men have different behaviors. You may agree upon doing some things before having sex but when you get into a private room, some of the men breach the agreement and do whatever they wish. He can 
force you to have anal sex. We do face a lot of 
challenges. 
–FSW, IDI, age 23, Mbeya
• All AGYW report that PrEP would alleviate their daily 
anxiety about becoming infected with HIV as they would 
be able to control their risk of HIV.  
“Using PrEP is easier because it is just about myself. I can decide to use PrEP unlike condoms where you may want to use but your partner doesn’t. Using PrEP is easier than condoms. 
–Married AGYW, IDI, age 20, Mbeya
IDI participants FGD participants
24 Number of AGYW 36
19–24 years Age range of participants 15–24 years
12 married/living with 
      partner
12 never married
Marital status 36 never married
15 primary school
9 secondary school
Highest education  
level attained 
24 primary school
12 secondary school
12 sex work
5 business
5 domestic
1 farming
1 unemployed
Occupation 28 domestic
6 business
2 farming
DEMOGRAPHIC CHARACTERISTICS OF PARTICIPANTS 
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Fear of stigma, side effects, and the 
impact of PrEP on their relationship 
are the key barriers noted by AGYW 
• Fear of HIV stigma from peers, parents, and sexual 
partner(s) is a commonly cited barrier to taking PrEP. 
Many fear that PrEP may be mistaken for ARVs leading 
to the misconception that they are HIV infected. Two 
participants commented:
“If you take these pills, your friends will isolate you knowing that you are HIV infected. Even men won’t seduce you anymore. Same to women, they won’t accept a man who is taking these pills.
“They will think differently because PrEP pills are similar to HIV pills, so people will think you are using ARVs.–FGD, ages 15–17, Dar es Salaam 
• Some AGYW note that their PrEP use could lead to 
relationship dissolution, loss of financial support, and 
violence from their male partners. Respondents note 
that if PrEP was used covertly without the partner’s 
knowledge, it would raise issues around trust and 
fidelity.
“…nowadays men have trust issues. So, if your partner sees you using PrEP, he will ask you a lot of questions.... It can be difficult to explain to him and he could perceive you negatively. ...the partner 
could become furious and wonder why his 
partner brings so much misunderstanding just 
because of pills. ...he could even take the pills 
away. If he was giving you money, he could 
stop doing so.
–FSW, IDI, age 19, Dar es Salaam
• Potential side effects of PrEP are also a key concern for 
many AGYW, who feel that they would negatively impact 
their ability to adhere to the daily regimen. Additionally, 
AGYW express concerns about PrEP’s potential impact 
on their ability for women to bear children in the future, 
which is especially concerning to unmarried AGYW and 
married AGYW without children. 
“They may think of side effects that are caused by PrEP. As you know nowadays these medications do cause a lot of effects especially for us who have not yet given birth. They can be worried about reproductive ability 
thereafter in the future. 
–FSW, IDI, age 23, Dar es Salaam 
Key facilitators to AGYW PrEP 
adherence are community 
education and sensitization, 
knowing one’s HIV status, and 
availability of PrEP free of charge 
and in conjunction with other services 
• Male partner, parental, and community support and 
sensitization around the uses and benefits of PreP 
would encourage AGYW’s use of PrEP. If these key 
constituents are properly educated about the use for 
PrEP, AGYW feel that they would encourage and support 
their continued use of PrEP.
“Once parents and the community at large are educated about PrEP, it would be easy for young women to use PrEP. This is because even the male partners could have been positive about it and they would also 
support young women in using PrEP. On the 
other hand, if parents are not aware and they 
do not know about PrEP, they would influence 
young women not to use it.
–FGD, ages 18–24, Dar es Salaam
• AGYW report that the relief associated with knowing 
they are HIV negative due to the 3-month HIV testing 
requirement associated with taking PrEP would 
encourage them to continue adhering to PrEP. 
“...if you use this medication, you will test negative for HIV when you go for test, you protect yourself against HIV. You know they don’t want to be infected with HIV. If you tell them in such a way, they accept it quickly.
–Married AGYW, IDI, age 21, Dar es Salaam
• AGYW prefer that PrEP be offered in comprehensive or 
multiple settings, such as public and private hospitals, 
dispensaries, and pharmacies, as these venues would 
make it less apparent which specific services they 
were seeking. Moreover, these settings offer both 
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care through knowledgeable health staff, including 
availability of female staff, counseling on proper use of 
medicines, HIV testing and counseling, as well as other 
services such as family planning. 
“At hospital is where medicines are being provided, there is counselling services, and there are many doctors. Also, it is the entry point for many service providers. Visiting the health center will be accompanied 
by seeing a doctor who will provide counseling 
to us and we will learn and understand many 
things.
–FSW, IDI, age 21, Mbeya 
• Most AGYW report they would take PrEP if it were 
offered free of charge. High costs would deter 
consistent, long term use of PrEP. Some AGYW are 
willing to pay a maximum of 200TSH ($.09USD) per 
pill to 10,000TSH ($4.47USD) for a 1-month supply of 
PrEP. Only a few participants say they could manage 
to find a way to use PrEP regardless of the cost. 
In response to a question if cost would cause the 
respondent to fail to use PrEP:
“Yes, I will end up having unprotected sex. ...it will depend on the financial position of a person. PrEP can be available at the health facility at cost. Whoever is able to pay will buy it. Those who are not able to pay 
will die. 
—FSW, IDI, age 22, Mbeya 
RECOMMENDATIONS 
• Ensure that demand creation activities include 
sensitization and education of communities, parents, 
and male partners of AGYW. 
• Train providers to deliver adequate education about 
PrEP to avoid misperceptions about its intended use, 
side effects, and efficacy. 
• Increase access to PrEP by integrating it into existing 
comprehensive health services, such as hospitals, 
dispensaries, and pharmacies, at no or low cost to 
ensure widespread coverage and uptake by the most 
vulnerable populations. 
REFERENCES 
1Tanzania Commission for AIDS (TACAIDS) et al. 2013. Tanzania HIV/
AIDS and Malaria Indicator Survey 2011-12. Dar es Salaam, Tanzania: 
TACAIDS, ZAC, NBS, OCGS, and ICF International.
2WHO. 2015. “Guideline on when to start antiretroviral therapy and on 
pre-exposure prophylaxis for HIV.” Geneva, Switzerland: WHO.
3Fonner, V. A. et al. 2016. “Effectiveness and safety of oral HIV 
preexposure prophylaxis for all populations,” AIDS 30(12): 1973.
4Van Damme, L. et al. 2012. “Preexposure prophylaxis for HIV infection 
among African women,” New England Journal of Medicine 367(5): 
411–422.
5Corneli, A. L. et al. 2014. “FEM-PrEP: adherence patterns and factors 
associated with adherence to a daily oral study product for pre-exposure 
prophylaxis,” Journal of Acquired Immune Deficiency Syndromes 66(3): 
324–331.
For more information, contact Nanlesta Pilgrim (npilgrim@
popcouncil.org), Lou Apicella (lapicella@popcouncil.org), or 
Catherine Kahabuka (ckahabuka@cskresearch.com). 
